G2 Investment Partners Management’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-305,000
Closed -$2.09M 73
2024
Q2
$2.09M Buy
305,000
+116,881
+62% +$1.07M 0.54% 58
2024
Q1
$1.93M Sell
188,119
-499,931
-73% -$3.7M 0.51% 55
2023
Q4
$5.7M Buy
688,050
+132,850
+24% +$955K 1.67% 28
2023
Q3
$3.47M Buy
555,200
+342,717
+161% +$1.49M 0.85% 42
2023
Q2
$924K Buy
+212,483
New +$472K 0.22% 69
2021
Q1
Sell
-234,000
Closed -$1.53M 96
2020
Q4
$1.53M Buy
+234,000
New +$1.72M 0.28% 56

Other funds holding LFMD

G2 Investment Partners Management's LFMD Position: Q3 2024 in Review

G2 Investment Partners Management sold out of LifeMD (LFMD) in Q3 2024, closing a stake of 305,000 shares — an estimated $2.09M sold.

G2 Investment Partners Management first reported a position in LFMD in Q4 2020 and held it in 6 quarters. The position peaked at $5.7M in Q4 2023. 101 funds tracked by Wall St. Rank hold LFMD as of Q3 2024.

  • G2 Investment Partners Management reported no remaining LifeMD position as of Q3 2024 after selling out during the quarter.
  • G2 Investment Partners Management sold 305,000 LifeMD shares in Q3 2024, an estimated $2.09M.
  • G2 Investment Partners Management first reported a position in LifeMD in Q4 2020 and held it in 6 quarters.
  • G2 Investment Partners Management's LifeMD position peaked at $5.7M in Q4 2023.
  • 101 funds tracked by Wall St. Rank held LifeMD as of Q3 2024.

Based on G2 Investment Partners Management's 13F filing for Q3 2024, filed 14 Nov 2024.